DIAL Webinars
DIAL Webinars
In the latest instalments of the Novartis sponsored DIAbetes Experts onLine (DIAL) webinar series, Professor Emeritus David Matthews, Professor Stefano del Prato, Professor Michael Stumvoll and Dr Païvi M. Paldánius discuss the key findings of the ground-breaking VERIFY trial and share their ideas about how these results might influence the way in which we treat early type 2 diabetes in the future.
DIAL Webinar 2019 – Professor Michael Stumvoll: Is diabetes progression inevitable, is it predictable and is it modifiable?
Can type 2 diabetes disease progression be prevented? What are the risks of delaying escalation of type 2 diabetes treatment? Find out what Professor Stumvoll has to say.
The videos on this site have been developed independently by the speaker and intended for non-promotional scientific purposes only. The views presented are that of the presenter and not necessarily those of the industry sponsor, Novartis Pharma AG. Time2DoMore is a trademark owned by Novartis Pharma AG. Following codes supersede any other material reference number appearing on the assets: GLEM/GAL/0072, 75, 79, 84, 99.
Date of preparation December 2019 GLEM/GAL/0099.